Biostar Pharmaceuticals Inc (BSPM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2016 | 12-2015 | 12-2014 | 12-2013 | 12-2012 | |
| Sales | 2,385 | 27,130 | 61,417 | 52,729 | 49,318 |
| Cost of Goods | 1,469 | 16,026 | 31,140 | 27,046 | 19,467 |
| Gross Profit | 915 | 11,104 | 30,276 | 25,683 | 29,851 |
| Operating Expenses | 4,949 | 34,887 | 31,729 | 25,221 | 52,104 |
| Operating Income | -3,564 | -23,758 | -1,313 | 508 | -21,786 |
| Interest Expense | 206 | 284 | 155 | 368 | 84 |
| Other Income | 725 | 249 | 3,002 | 2,515 | 297 |
| Pre-tax Income | -3,045 | -23,793 | 1,535 | 2,656 | -21,574 |
| Income Tax | 2,653 | 1,320 | -3,314 | 1,847 | -1,576 |
| Net Income Continuous | -5,698 | -25,113 | 4,848 | 809 | -19,997 |
| Net Income | $-5,698 | $-25,113 | $4,848 | $809 | $-19,997 |
| EPS Basic Total Ops | -2.50 | -11.40 | 2.30 | 0.49 | -14.63 |
| EPS Basic Continuous Ops | -2.48 | -11.36 | 2.34 | 0.49 | -14.62 |
| EPS Diluted Total Ops | -2.50 | -11.40 | 2.30 | 0.49 | -14.63 |
| EPS Diluted Continuous Ops | -2.48 | -11.36 | 2.34 | 0.49 | -14.62 |
| EPS Diluted Before Non-Recurring Items | -2.48 | -11.36 | 2.31 | 0.49 | -9.73 |
| EBITDA(a) | $-2,422 | $-21,437 | $1,774 | $3,295 | $-19,958 |